candesartan has been researched along with Hypotension, Orthostatic in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Hypotension, Orthostatic: A significant drop in BLOOD PRESSURE after assuming a standing position. Orthostatic hypotension is a finding, and defined as a 20-mm Hg decrease in systolic pressure or a 10-mm Hg decrease in diastolic pressure 3 minutes after the person has risen from supine to standing. Symptoms generally include DIZZINESS, blurred vision, and SYNCOPE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wuerzner, G | 1 |
Chioléro, A | 1 |
Maillard, M | 1 |
Nussberger, J | 1 |
Brunner, HR | 1 |
Burnier, M | 1 |
Chiclero, A | 1 |
1 trial available for candesartan and Hypotension, Orthostatic
Article | Year |
---|---|
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Topics: Acute Disease; Adult; Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; B | 2004 |